Guillain-Barré syndrome

Lancet

Volumn 366, Issue 9497, 2005, Pages 1653-1666

  Hughes, Richard A C ^a   Cornblath, David R ^b  

^a GUY S HOSPITAL   (United Kingdom)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN;

CAMPYLOBACTER JEJUNI; CLINICAL TRIAL; CONFERENCE PAPER; CROSS REACTION; DRUG EFFICACY; GENE TARGETING; GENETIC SUSCEPTIBILITY; GUILLAIN BARRE SYNDROME; HUMAN; INFLAMMATION; MEDICAL RESEARCH; MOTOR NERVE; NERVE ENDING; NERVE FIBER MEMBRANE; NEUROPHYSIOLOGY; PATHOGENESIS; PLASMAPHERESIS; PRIORITY JOURNAL; RABBIT; T LYMPHOCYTE;

EID: 27644558148     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)67665-9     Document Type: Conference Paper

References (173)

1. G Guillain, JA Barré, A Strohl Sur un syndrome de radiculo-névrite avec hyperalbuminose du liquide céphalo-rachidien sans réaction cellulaire. Remarques sur les caractéres cliniques et graphiques des réflexes tendineux Bull Soc Méd Hôp Paris 40 1916 1462 1470
2. J Pritchard, RA Hughes Guillain-Barré syndrome Lancet 363 2004 2186 2188
3. AK Asbury, BG Arnason, RD Adams The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis Medicine 48 1969 173 215
4. JW Prineas Acute idiopathic polyneuritis. An electronmicroscope study Lab Invest 26 1972 133 147
5. GM McKhann, DR Cornblath, TW Ho, CY Li, AY Bai, HS Wu Clinical and electrophysiological aspects of acute paralytic disease of children and young adults in northern China Lancet 338 1991 593 597
6. GM McKhann, DR Cornblath, JW Griffin Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China Ann Neurol 33 1993 333 342
7. JW Griffin, CY Li, TW Ho Guillain-Barré syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases Brain 118 1995 577 595
8. JW Griffin, CY Li, TW Ho Pathology of the motor-sensory axonal Guillain-Barré syndrome Ann Neurol 39 1996 17 28
9. RDM Hadden, DR Cornblath, RAC Hughes Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome Ann Neurol 44 1998 780 788
10. G Paradiso, J Tripoli, S Galicchio, N Fejerman Epidemiological, clinical, and electrodiagnostic findings in childhood Guillain-Barré syndrome: a reappraisal Ann Neurol 46 1999 701 707
11. K Ogawara, S Kuwabara, M Mori, T Hattori, M Koga, N Yuki Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan Ann Neurol 48 2000 624 631
12. M Asahina, S Kuwabara, A Suzuki, T Hattori Autonomic function in demyelinating and axonal subtypes of Guillain-Barré syndrome Acta Neurol Scand 105 2002 44 50
13. M Fisher Syndrome of ophthalmoplegia, ataxia and areflexia N Engl J Med 255 1956 57 65
14. RAC Hughes Guillain-Barré Syndrome 1990 Springer-Verlag Heidelberg
15. D Annane, A Gunn, RAC Hughes Neuromuscular Disease Group About The Cochrane Collaboration (Collaborative Review Groups) 2 2005 NEUROMUSC
16. RAC Hughes, JH Rees Clinical and epidemiological features of Guillain-Barré syndrome J Infect Dis 176 suppl 2 1997 S92 S98
17. JH Rees, RD Thompson, NC Smeeton, RAC Hughes An epidemiological study of Guillain-Barré syndrome in South East England J Neurol Neurosurg Psychiatry 64 1998 74 77
18. G Bogliun, E Beghi Incidence and clinical features of acute inflammatory polyradiculoneuropathy in Lombardy, Italy, 1996 Acta Neurol Scand 110 2004 100 106
19. A Chio, D Cocito, M Leone, MT Giordana, G Mora, R Mutani Guillain-Barré syndrome: a prospective, population-based incidence and outcome survey Neurology 60 2003 1146 1150
20. R Van Koningsveld, PA van Doorn, PI Schmitz, CW Ang, FG Van der Meché Mild forms of Guillain-Barré syndrome in an epidemiologic survey in The Netherlands Neurology 54 2000 620 625
21. V Govoni, E Granieri Epidemiology of the Guillain-Barré syndrome Curr Opin Neurol 14 2001 605 613
22. V Govoni, E Granieri, M Manconi, J Capone, I Casetta Is there a decrease in Guillain-Barré syndrome incidence after bovine ganglioside withdrawal in Italy? A population-based study in the Local Health District of Ferrara, Italy J Neurol Sci 216 2003 99 103
23. Q Cheng, DS Wang, GX Jiang Distinct pattern of age-specific incidence of Guillain-Barré syndrome in Harbin, China J Neurol 249 2002 25 32
24. R Van Koningsveld, R Rico, I Gerstenbluth Gastroenteritis-associated Guillain-Barré syndrome on the Caribbean island Curacao Neurology 56 2001 1467 1472
25. GC Roman Tropical neuropathies Hartung H-P Peripheral Neuropathies: Part 1 1995 Baillière Tindall London 469 487
26. MJ Blaser, A Olivares, DN Taylor, DR Cornblath, GM McKhann Campylobacter serology in patients with Chinese paralytic syndrome Lancet 338 1991 308
27. JB Winer, RAC Hughes, MJ Anderson, DM Jones, H Kangro, RFP Watkins A prospective study of acute idiopathic neuropathy. II. Antecedent events J Neurol Neurosurg Psychiatry 51 1988 613 618
28. Guillain-Barré Syndrome Study Group Guillain-Barré syndrome: an Italian multicentre case-control study Neurol Sci 21 2000 229 234
29. RDM Hadden, H Karch, H-P Hartung Preceding infections, immune factors and outcome in Guillain-Barré syndrome Neurology 56 2001 758 765
30. JE Kaplan, P Katona, ES Hurwitz, LB Schonberger Guillain-Barré syndrome in the United States, 1979-1980 and 1980-1981. Lack of an association with influenza vaccination JAMA 248 1982 698 700
31. JE Kaplan, LB Schonberger, ES Hurwitz, P Katona Guillain-Barré syndrome in the United States 1978-1981; additional observations from the national surveillance system Neurology 33 1983 633 637
32. AD Langmuir, DJ Bregman, LT Kurland, N Nathanson, M Victor An epidemiologic and clinical evaluation of GBS reported in association with administration of swine influenza vaccines Am J Epidemiol 119 1984 841 879
33. P Haber, F DeStefano, FJ Angulo Guillain-Barré syndrome following influenza vaccination JAMA 292 2004 2478 2481
34. T Lasky, GJ Terracciano, L Magder The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines N Engl J Med 339 1998 1797 1802
35. RAC Hughes, NA Gregson, RDM Hadden, KJ Smith Pathogenesis of Guillain-Barré syndrome J Neuroimmunol 100 1999 74 97
36. T Hemachudha, DE Griffin, WW Chen, RT Johnson Immunologic studies of rabies vaccination-induced GBS Neurology 38 1988 375 378
37. AK Asbury, DR Cornblath Assessment of current diagnostic criteria for Guillain-Barré syndrome Ann Neurol 27 suppl 1990 S21 S24
38. Cornblath, DR. Acute onset flaccid paralysis. Geneva:WHP-IREN/MNH/EPI/93. 3, 1993.
39. R Hughes, E Sanders, S Hall, P Atkinson, A Colchester, J Payan Subacute idiopathic demyelinating polyradiculoneuropathy Arch Neurol 49 1992 612 616
40. SJ Oh, K Kurokawa, DF De Almeida, HF Ryan Jr, GC Claussen Subacute inflammatory demyelinating polyneuropathy Neurology 61 2003 1507 1512
41. Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force Research criteria for the diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) Neurology 41 1991 617 618
42. M Odaka, N Yuki, K Hirata Patients with chronic inflammatory demyelinating polyneuropathy initially diagnosed as Guillain-Barré syndrome J Neurol 250 2003 913 916
43. K Mori, N Hattori, M Sugiura Chronic inflammatory demyelinating polyneuropathy presenting with features of GBS Neurology 58 2002 979 982
44. L Ruts, R Van Koningsveld, PA van Doorn Distinguishing acute onset CIDP from Guillain-Barré syndrome with treatment related fluctuations Neurology 65 2005 138 140
45. TW Ho, B Mishu, CY Li Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies Brain 118 1995 597 605
46. DR Cornblath Electrophysiology in Guillain-Barré syndrome Ann Neurol 27 suppl 1990 S17 S20
47. TW Ho, HJ Willison, I Nachamkin Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome Ann Neurol 45 1999 168 173
48. J Meulstee, FG van der Meché Electrodiagnostic studies in the Dutch multicentre Guillain-Barré study: a review J Peripher Nerv Syst 2 1997 143 230
49. PYK van den Bergh, F Piéret Electrodiagnostic criteria for acute and chronic inflammatory demyelinating polyradiculoneuropathy Muscle Nerve 29 2004 565 574
50. EH Lambert, DW Mulder Nerve conduction in the Guillain-Barré syndrome Electroencephalography and Clinical Neurophysiology 17 1964 86 93
51. JG McLeod Electrophysiological studies in the Guillain-Barré syndrome Ann Neurol 9 1981 20 27
52. JW Albers, PD Donofrio, TK McGonagle Sequential electrodiagnostic abnormalities in acute inflammatory demyelinating polyradiculoneuropathy Muscle Nerve 6 1985 504 509
53. JW Albers, JJ Kelly Acquired inflammatory demyelinating polyneuropathies: clinical and electrodiagnostic features Muscle Nerve 12 1989 435 451
54. AH Ropper, EFM Wijdicks, BT Shahani Electrodiagnostic abnormalities in 113 consecutive patients with Guillain-Barré syndrome Arch Neurol 47 1990 881 887
55. PH Gordon, AJ Wilbourn Early electrodiagnostic findings in Guillain-Barré syndrome Arch Neurol 58 2001 913 917
56. RK Olney, MJ Aminof Electrodiagnostic features of the Guillain-Barré syndrome: The relative sensitivity of different techniques Neurology 40 1990 471 475
57. WF Brown, TE Feasby Conduction block and denervation in Guillain-Barré polyneuropathy Brain 107 1984 219 239
58. WF Brown, R Snow Patterns and severity of conduction abnormalities in Guillain-Barré syndrome J Neurol Neurosurg Psychiatry 54 1991 768 774
59. S Kuwabara, M Mori, K Ogawara Axonal involvement at the common entrapment sites in Guillain-Barré syndrome with IgG anti-GM1 antibody Muscle Nerve 22 1999 840 845
60. NM Murray, DT Wade The sural sensory action potential in Guillain-Barré syndrome Muscle Nerve 3 1980 444
61. SM Hall, RAC Hughes, J Payan, PF Atkinson, I McColl, A Gale Motor nerve biopsy in severe Guillain-Barré syndrome Ann Neurol 31 1992 441 444
62. J Berciano, J Figols, A García Fulminant Guillain-Barré syndrome with universal inexcitability of peripheral nerves: aA clinicopathological study Muscle Nerve 20 1997 846 857
63. JW Prineas Pathology of the Guillain-Barré syndrome Ann Neurol 9 suppl 1981 6 19
64. PW Lampert Electron microscopic studies on ordinary and hyperacute experimental allergic encephalomyelitis Acta Neuropathol 9 1967 99 126
65. A Créange, T Sharshar, T Planchenault Matrix metalloproteinase-9 is increased and correlates with severity in Guillain-Barré syndrome Neurology 53 1999 1683 1691
66. BC Kieseier, R Kiefer, R Gold, B Hemmer, HJ Willison, HP Hartung Advances in understanding and treatment of immune-mediated disorders of the peripheral nervous system Muscle Nerve 30 2004 131 156
67. CE Hafer-Macko, KA Sheikh, CY Li Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy Ann Neurol 39 1996 627 637
68. JW Griffin, CY Li, C Macko Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barré syndrome J Neurocytol 25 1996 33 51
69. C Hafer-Macko, ST Hsieh, CY Li Acute motor axonal neuropathy: an antibody-mediated attack on axolemma Ann Neurol 40 1996 635 644
70. TW Ho, CY Li, DR Cornblath Patterns of recovery in the Guillain-Barré syndromes Neurology 48 1997 695 700
71. S Kuwabara, H Bostock, K Ogawara The refractory period of transmission is impaired in axonal Guillain-Barré syndrome Muscle Nerve 28 2003 683 689
72. A Hiraga, M Mori, K Ogawara, T Hattori, S Kuwabara Differences in patterns of progression in demyelinating and axonal Guillain-Barré sindromes Neurology 61 2003 471 474
73. MS Phillips, S Stewart, JR Anderson Neuropathological findings in Miller-Fisher syndrome J Neurol Neurosurg Psychiatry 47 1984 492 495
74. RJ Guiloff Peripheral nerve conduction in Miller Fisher syndrome J Neurol Neurosurg Psychiatry 40 1977 801 807
75. RD Fross, J Daube Neuropathy in the Miller-Fisher syndrome: clinical and electrophysiologic findings Neurology 37 1987 1493 1498
76. AN Al-Din, M Anderson, ER Bickerstaff, I Harvey Brainstem encephalitis and the syndrome of Miller-Fisher: a clinical study Brain 105 1982 481 495
77. M Kadlubowski, RAC Hughes Identification of the neuritogen responsible for experimental allergic neuritis Nature 277 1979 140 141
78. P Milner, CA Lovelidge, WA Taylor, RAC Hughes P0 myelin protein produces experimental allergic neuritis in Lewis rats J Neurol Sci 79 1987 275 285
79. CM Gabriel, RAC Hughes, SE Moore, KJ Smith, FS Walsh Induction of experimental neuritis with peripheral myelin protein 22 Brain 121 1998 1895 1902
80. B Salomon, L Rhee, H Bour-Jordan Development of spontaneous autoimmune peripheral polyneuropathy in B7-2-deficient NOD mice J Exp Med 194 2001 677 684
81. M Koga, N Yuki, Y Tsukada, K Hirata, Y Matsumoto CDR3 spectratyping analysis of the T cell receptor repertoire in Guillain-Barré and Fisher syndromes J Neuroimmunol 141 2003 112 117
82. KR Bulsara, PW Baron, JE Tuttle-Newhall, PA Clavien, J Morgenlander Guillain-Barré syndrome in organ and bone marrow transplant patients Transplantation 71 2001 1169 1172
83. A Khalili-Shirazi, RAC Hughes, S Brostoff, C Linington, N Gregson T cell response to myelin proteins in Guillain-Barré syndrome J Neurol Sci 111 1992 200 203
84. 0 protein J Neuroimmunol 54 1994 29 34
85. 2 myelin proteins in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy J Neuroimmunol 46 1993 245 252
86. C Dahle, C Ekerfelt, M Vrethem, M Samuelsson, J Ernerudh T helper type 2 like cytokine responses to peptides from P0 and P2 myelin proteins during the recovery phase of Guillain-Barré syndrome J Neurol Sci 153 1997 54 60
87. MS Kwa, IN van Schaik, A Brand, F Baas, M Vermeulen Investigation of serum response to PMP22, connexin 32 and P(0) in inflammatory neuropathies J Neuroimmunol 116 2001 220 225
88. CM Gabriel, NA Gregson, RAC Hughes Anti-PMP22 antibodies in patients with inflammatory neuropathy J Neuroimmunol 104 2000 139 146
89. Q Hao, T Saida, S Kuroki Antibodies to gangliosides and galactocerebroside in patients with Guillain-Barré syndrome with preceding Campylobacter jejuni and other identified infections J Neuroimmunol 81 1998 116 126
90. K Susuki, M Odaka, M Mori, K Hirata, N Yuki Acute motor axonal neuropathy after Mycoplasma infection: evidence of molecular mimicry Neurology 62 2004 949 956
91. S Kusunoki, J Shimizu, R Chiba, Y Ugawa, S Hitoshi, I Kanazawa Experimental sensory neuropathy induced by sensitisation with ganglioside GD1b Ann Neurol 39 1996 324 331
92. K Susuki, Y Nishimoto, M Yamada Acute motor axonal neuropathy rabbit model: Immune attack on nerve root axons Ann Neurol 54 2003 383 388
93. N Yuki, M Yamada, M Koga Animal model of axonal Guillain-Barré syndrome induced by sensitization with GM1 ganglioside Ann Neurol 49 2001 712 720
94. I Illa, N Ortiz, E Gallard, C Juarez, JM Grau, MC Dalakas Acute axonal Guillain-Barré syndrome with IgG antibodies against motor axons following parenteral gangliosides Ann Neurol 38 1995 218 224
95. KA Sheikh, G Zhang, Y Gong, RL Schnaar, JW Griffin An anti-ganglioside antibody-secreting hybridoma induces neuropathy in mice Ann Neurol 56 2004 228 239
96. 1 IgG or IgM to induce conduction block following intraneural transfer Muscle Nerve 18 1995 388 394
97. N Hirota, R Kaji, H Bostock The physiological effect of anti-GM1 antibodies on saltatory conduction and transmembrane currents in single motor axons Brain 120 1997 2159 2169
98. T Takigawa, H Yasuda, R Kikkawa, Y Shigeta, T Saida, H Kitasato Antibodies against GM1 ganglioside affect K+ and Na+ currents in isolated rat myelinated nerve fibers Ann Neurol 37 1995 436 442
99. M Roberts, H Willison, A Vincent, J Newsom-Davis Serum factor in Miller-Fisher variant of Guillain-Barré syndrome and neurotransmitter release Lancet 343 1994 454 455
100. JJ Plomp, PC Molenaar, GM O'Hanlon Miller Fisher anti-GQ1b antibodies: alpha-Latrotoxin-like effects on motor end plates Ann Neurol 45 1999 189 199
101. SK Halstead, GM O'Hanlon, PD Humphreys Anti-disialoside antibodies kill perisynaptic Schwann cells and damage motor nerve terminals via membrane attack complex in a murine model of neuropathy Brain 127 2004 2109 2123
102. JA Goodfellow, T Bowes, K Sheikh Overexpression of GD1a ganglioside sensitizes motor nerve terminals to anti-GD1a antibody-mediated injury in a model of acute motor axonal neuropathy J Neurosci 25 2005 1620 1628
103. K Taguchi, J Ren, I Utsunomiya Neurophysiological and immunohistochemical studies on Guillain-Barré syndrome with IgG anti-GA1NAc-GD1a antibodies: effects on neuromuscular transmission J Neurol Sci 225 2004 91 98
104. NM van Sorge, LH Van den Berg, K Geleijns Anti-GM1 IgG antibodies induce leukocyte effector functions via Fcgamma receptors Ann Neurol 53 2003 570 579
105. RDM Hadden, NA Gregson, RAC Hughes Opening of the blood-nerve barrier in experimental autoimmune neuritis Ann Neurol 46 1999 484 485
106. RDM Hadden, NA Gregson, R Gold, KJ Smith, RAC Hughes Accumulation of immunoglobulin in spinal roots in adoptive transfer experimental autoimmune neuritis Neuropathol Appl Neurobiol 28 2002 489 497
107. HJ Willison, N Yuki Peripheral neuropathies and anti-glycolipid antibodies Brain 125 2002 2591 2625
108. NM van Sorge Pathogenicity of anti-ganglioside antibodies in the Guillain-Barré syndrome Autoimmun Rev 3 2004 61 68
109. A Hiraga, S Kuwabara, K Ogawara Patterns and serial changes in electrodiagnostic abnormalities of axonal Guillain-Barré syndrome Neurology 64 2005 856 860
110. K Kaida, S Kusunoki, K Kamakura, K Motoyoshi, I Kanazawa GalNAc-GD1a in human peripheral nerve: target sites of anti-ganglioside antibody Neurology 61 2003 465 470
111. A Chiba, S Kusunoki, H Obata, R Machinami, I Kanazawa Ganglioside composition of the human cranial nerves, with special reference to pathophysiology of Miller Fisher syndrome Brain Res 745 1997 32 36
112. Y Gong, Y Tagawa, MP Lunn Localization of major gangliosides in the PNS: implications for immune neuropathies Brain 125 2002 2491 2506
113. S Kusunoki, D Morita, S Ohminami, S Hitoshi, I Kanazawa Binding of immunoglobulin G antibodies in Guillain-Barré syndrome sera to a mixture of GM1 and a phospholipid: possible clinical implications Muscle Nerve 27 2003 302 306
114. A Khalili-Shirazi, N Gregson, M Londei, L Summers, RAC Hughes The distribution of CD1 molecules in inflammatory neuropathy J Neurol Sci 158 1998 154 163
115. A Ben-Smith, JSH Gaston, PC Barber, JB Winer Isolation and characterisation of T lymphocytes from sural nerve biopsies in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy J Neurol Neurosurg Psychiatry 61 1996 362 368
116. SN Scelsa Blood gammadelta T cells, Campylobacter jejuni, and GM1 titers in Guillain-Barré syndrome Muscle Nerve 30 2004 423 432
117. CW Ang, BC Jacobs, JD Laman The Guillain-Barré syndrome: a true case of molecular mimicry Trends Immunol 25 2004 61 66
118. JH Rees, SE Soudain, NA Gregson, RAC Hughes A prospective case control study to investigate the relationship between Campylobacter jejuni infection and Guillain-Barré syndrome N Engl J Med 333 1995 1374 1379
119. S Kuwabara, K Ogawara, S Misawa Does Campylobacter jejuni infection elicit "demyelinating" Guillain-Barré syndrome? Neurology 63 2004 529 533
120. I Nachamkin, J Liu, M Li Campylobacter jejuni from patients with Guillain-Barré syndrome preferentially expresses a GD(1a)-like epitope Infect Immun 70 2002 5299 5303
121. PC Godschalk, AP Heikema, M Gilbert The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barré syndrome J Clin Invest 114 2004 1659 1665
122. N Yuki, K Susuki, M Koga Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barré syndrome Proc Natl Acad Sci USA 101 2004 11404 11409
123. 1b ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients with Fisher's syndrome Ann Neurol 36 1994 791 793
124. M Koga, M Gilbert, J Li Antecedent infections in Fisher syndrome: a common pathogenesis of molecular mimicry Neurology 64 2005 1605 1611
125. CS Goodyear, GM O'Hanlon, JJ Plomp Monoclonal antibodies raised against Guillain-Barré syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations J Clin Invest 104 1999 697 708
126. GM O'Hanlon, JJ Plomp, M Chakrabarti Anti-GQ1b ganglioside antibodies mediate complement-dependent destruction of the motor nerve terminal Brain 124 2001 893 906
127. M Mori, S Kuwabara, M Miyake Haemophilus influenzae has a GM1 ganglioside-like structure and elicits Guillain-Barré syndrome Neurology 52 1999 1282 1284
128. M Koga, N Yuki, T Tai, K Hirata Miller Fisher syndrome and Haemophilus influenzae infection Neurology 57 2001 686 691
129. A Khalili-Shirazi, N Gregson, I Gray, J Rees, J Winer, RAC Hughes Antiganglioside antibodies in Guillain-Barré syndrome after a recent cytomegalovirus infeciton J Neurol Neurosurg Psychiatry 66 1999 376 379
130. C Gorodezky, B Varela, LE Castro-Escobar, A Chavez-Negrete, A Escobar-Gutierrez, J Martinez-Mata HLA-DR antigens in Mexican patients with Guillain-Barré syndrome J Neuroimmunol 4 1983 1 7
131. A N Yuki, S Sato, S Fujimoto Serotype of Campylobacter jejuni, HLA, and the Guillain- Barré syndrome Muscle Nerve 15 1992 968 969
132. JH Rees, RW Vaughan, E Kondeatis, RAC Hughes HLA-Class II alleles in Guillain-Barré syndrome and Miller Fisher syndrome and their association with preceding Campylobacter jejuni infection J Neuroimmunol 62 1995 53 57
133. JJ Ma, M Nishimura, H Mine HLA and T-cell receptor gene polymorphisms in Guillain-Barré syndrome Neurology 51 1998 379 384
134. EE Magira, M Papaioakim, I Nachamkin Differential distribution of HLA-DQ beta/DR beta epitopes in the two forms of Guillain-Barré syndrome, acute motor axonal neuropathy and acute inflammatory demyelinating polyneuropathy (AIDP): identification of DQ beta epitopes associated with susceptibility to and protection from AIDP J Immunol 170 2003 3074 3080
135. DS Monos, M Papaioakim, TW Ho, CY Li, GM McKhann Differential distribution of HLA alleles in two forms of Guillain-Barré syndrome J Infect Dis 176 suppl 2 1997 S180 S182
136. K Geleijns, GM Schreuder, BC Jacobs HLA class II alleles are not a general susceptibility factor in Guillain-Barré syndrome Neurology 64 2005 44 49
137. NM van Sorge, W-L van der Pol, MD Jansen Severity of Guillain- Barré syndrome is associated with Fc ReceptorIII polymorphisms J Neuroimmunol 162 2005 157 164
138. K Geleijns, BC Jacobs, RW Van, AP Tio-Gillen, JD Laman, PA van Doorn Functional polymorphisms in LPS receptors CD14 and TLR4 are not associated with disease susceptibility or Campylobacter jejuni infection in Guillain- Barré patients J Neuroimmunol 150 2004 132 138
139. JJ Ma, M Nishimura, H Mine Genetic contribution of the tumor necrosis factor region in Guillain-Barré syndrome Ann Neurol 44 1998 815 818
140. LH Visser, PIM Schmitz, J Meulstee, PA van Doorn, FGA van der Meché Prognostic factors of Guillain-Barré syndrome after intravenous immunoglobulin or plasma exchange Neurology 53 1999 598 604
141. IS Merkies, PI Schmitz, JP Samijn, FG van der Meché, PA van Doorn Fatigue in immune-mediated polyneuropathies. European Inflammatory Neuropathy Cause and Treatment (INCAT) Group Neurology 53 1999 1648 1654
142. CD de la Cour, J Jakobsen Residual neuropathy in long-term population-based follow-up of Guillain-Barré syndrome Neurology 64 2005 246 253
143. DY Bradshaw, HR Jones Jr Guillain-Barré syndrome in children: Clinical course, electrodiagnosis, and prognosis Muscle Nerve 15 1992 500 506
144. Z Ammache, AK Afifi, CK Brown, J Kimura Childhood Guillain-Barré syndrome: clinical and electrophysiologic features predictive of outcome J Child N 16 2001 477 483
145. DM Green, AH Ropper Mild Guillain-Barré syndrome Arch Neurol 58 2001 1098 1101
146. A Hiraga, M Mori, K Ogawara Recovery patterns and long term prognosis for axonal Guillain-Barré syndrome J Neurol Neurosurg Psychiatry 76 2005 719 722
147. RAC Hughes, E Wijdicks, RJ Barohn Supportive Care for Guillain-Barré syndrome Arch Neurol 62 2005 1194 1198
148. JM Meythaler Rehabilitation of Guillain-Barré syndrome Arch Phys Med Rehabil 78 1997 872 879
149. AJAM Bernsen, AEJ De Jager, PIM Schmitz, FGA van der Meché Long-term impact on work and private life after Guillain-Barré syndrome J Neurol Sci 201 2002 13 17
150. RAJAM Bernsen, HM Jacobs, AEJ De Jager, FGA van der Meché Residual health status after Guillain-Barré Syndrome J Neurol Neurosurg Psychiatry 62 1997 637 640
151. RAJAM Bernsen, AEJ De Jager, PIM Schmitz, FGA van der Meché Residual physical outcome and daily living 3 to 6 years after Guillain- Barré syndrome Neurology 53 1999 409 410
152. C Dornonville de la Cour, H Andersen, E Stålberg, A Fuglsang-Frederiksen, J Jakobsen Electrophysiological signs of permanent axonal loss in a follow-up study of patients with Guillain-Barré syndrome Muscle Nerve 31 2005 70 77
153. MP Garssen, JB Bussmann, PI Schmitz Physical training and fatigue, fitness, and quality of life in Guillain-Barré syndrome and CIDP Neurology 63 2004 2393 2395
154. J Pritchard, R Mukherjee, RAC Hughes The risk of relapse of Guillain-Barré syndrome or chronic inflammatory demyelinating polyradiculoneuropathy following immunisation J Neurol Neurosurg Psychiatry 73 2002 348 349
155. JC Raphaël, S Chevret, RA Hughes, D Annane Plasma exchange for Guillain-Barré syndrome Cochrane Database Syst Rev 2 2002 CD001798
156. The Guillain-Barré Syndrome Study Group Plasmapheresis and acute Guillain-Barré syndrome Neurology 35 1985 1096 1104
157. GM McKhann, JW Griffin, DR Cornblath Plasmapheresis and Guillain-Barré syndrome: analysis of prognostic factors and the effect of plasmapheresis Ann Neurol 23 1988 347 353
158. French Cooperative Group on plasma exchange in Guillain-Barré syndrome Appropriate number of plasma exchanges in Guillain-Barré syndrome Ann Neurol 41 1997 298 306
159. H Espérou, MC Jars Guincestre, F Bolgert, JC Raphael, I Durand-Zaleski French Cooperative Group on plasma exchange in Guillain-Barré syndrome. Cost-effectiveness of plasma exchange therapy for the treatment of Guillain-Barré syndrome Intensive Care Med 26 2000 1094 1100
160. FGA van der Meché, PIM Schmitz Dutch Guillain-Barré Study Group A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome N Engl J Med 326 1992 1123 1129
161. RA Hughes, JC Raphael, AV Swan, PA van Doorn Intravenous immunoglobulin for Guillain-Barré syndrome Cochrane Database Syst Rev 2 2001 CD002063
162. MC Dalakas Intravenous immunoglobulin in autoimmune neuromuscular diseases JAMA 291 2004 2367 2375
163. RAC Hughes, E Wijdicks, RJ Barohn Practice parameter: Immunotherapy for Guillain-Barré syndrome: report of the Quality Standards Subcommittee of the American Academy of Neurology Neurology 61 2003 736 740
164. R Korinthenberg, J Schessl, J Kirschner, JS Möntning Intravenous immunoglobulin in the treatment of childhood Guillain-Barré syndrome Pediatrics 116 2005 226 228
165. P Farcas, L Avnun, YO Herishanu, I Wirguin Efficacy of repeated intravenous immunoglobulin in severe unresponsive Guillain-Barré syndrome Lancet 350 1997 1747
166. RAC Hughes, FG van der Meché Corticosteroids for treating Guillain-Barré syndrome Cochrane Database Syst Rev 2 2000 CD001446
167. R Van Koningsveld, PIM Schmitz, FGA van der Meché Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barré syndrome: randomised trial Lancet 363 2004 192 196
168. MM Rich, MJ Pinter, SD Craner, RL Barchi Loss of electrical excitability in an animal model of acute quadriplegic myopathy Ann Neurol 43 1998 171 179
169. MM Rich, MJ Pinter Sodium channel inactivation in an animal model of acute quadriplegic myopathy Ann Neurol 50 2001 26 33
170. HJ Willison, K Townson, J Veitch Synthetic disialylgalactose immunoadsorbents deplete anti-GQ1b antibodies from autoimmune neuropathy sera Brain 127 2004 680 691
171. J Pritchard, IA Gray, ZR Idrissova A randomized controlled trial of recombinant interferon-beta 1a in Guillain-Barré syndrome Neurology 61 2003 1282 1284
172. DA Bechtold, X Yue, RM Evans, M Davies, NA Gregson, KJ Smith Axonal protection in experimental autoimmune neuritis by the sodium channel blocking agent flecainide Brain 128 2005 18 28
173. S Bensa, RDM Hadden, A Hahn, RAC Hughes, HJ Willison Randomised controlled trial of brain-derived neurotrophic factor in Guillain-Barré syndrome Eur J Neurol 7 2000 423 426